A tiny chemistry hack just made mRNA vaccines safer, stronger, and smarter

Publication date: Jul 21, 2025

Less Inflammation, Higher Performance With these encouraging signs of reduced inflammation, the researchers next tested whether the new lipids also improved vaccine performance. The new lipids also gave cancer-fighting T cells a boost, helping them recognize and destroy tumor cells more efficiently — and with less oxidative stress. By checking various markers associated with oxidative stress, the researchers compared the inflammatory effects of LNPs formulated using different lipids. Finally, when the team used the C-a16 lipids for preparing COVID-19 mRNA vaccines, the immune response in animal models was five times stronger than with standard formulations. “By causing less disruption to cellular machinery, the new, phenol-containing lipids can enhance a wide range of LNP applications,” says Kim. The C-a16 lipids also helped gene-editing tools like CRISPR do a better job fixing the faulty gene that causes hATTR. C-a16 LNPs not only produced longer-lasting effects, but also improved the efficacy of gene-editing tools like CRISPR and the potency of vaccines for treating cancer.

Concepts Keywords
Cancer A16
Fireflies Covid
Sandwich Engineering
Smarter Found
Tr002776 Inflammation
Lipid
Lipids
Lnps
Mitchell
Mrna
Phenol
Reaction
Vaccines

Semantics

Type Source Name
disease IDO immune response
pathway KEGG Melanoma
disease MESH melanoma
disease MESH hereditary transthyretin amyloidosis
disease MESH liver disease
disease MESH causes
drug DRUGBANK Oxygen
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH Genetic Disease
disease MESH oxidative stress
drug DRUGBANK Activated charcoal
disease IDO history
drug DRUGBANK Olive oil
drug DRUGBANK Tropicamide
drug DRUGBANK Phenol
disease MESH cancer
disease MESH inflammation
disease MESH COVID-19

Original Article

(Visited 8 times, 1 visits today)